
BACKGROUND Children with cystic fibrosis (CF) experience chronic inflammation and early glucose abnormalities. Whether dietary inflammatory potential is associated with glycemic outcomes in pediatric CF remains unclear. OBJECTIVE To examine associations of the Dietary Inflammatory Index (DII) with continuous glucose monitoring (CGM) metrics and systemic inflammatory markers in children with CF. METHODS This exploratory cross-sectional study included 24 clinically stable children with CF aged 6-18 years who were not receiving CFTR modulator therapy. DII scores were calculated from three non-consecutive 24-h dietary recalls. CGM-derived outcomes included mean glucose, time in range (TIR), time above range (TAR), glucose variability, and glucose management indicator (GMI). Inflammatory markers were measured using ELISA. Associations were examined using multivariable regression adjusted for age and sex. RESULTS After adjustment for age and sex, higher DII scores were associated with higher mean glucose (β = 0.512, p = 0.021), GMI (β = 0.583, p = 0.011), and TAR (β = 0.466, p = 0.044). The inverse association with TIR was not statistically significant (β = -0.421, p = 0.070). DII was also positively associated with log-CRP (β = 0.528, p = 0.037), whereas other inflammatory markers were not significantly associated with DII. CONCLUSION Higher dietary inflammatory potential was associated with greater glycemic exposure and CRP in children with CF. These exploratory findings warrant confirmation in larger longitudinal studies, including CFTR modulator-treated cohorts.